Feeding and metabolism in mice lacking pituitary adenylate cyclase-activating polypeptide

被引:44
作者
Adams, Bruce A. [1 ,2 ]
Gray, Sarah L. [3 ]
Isaac, Emma R. [1 ]
Bianco, Antonio C. [4 ]
Vidal-Puig, Antonio J. [3 ]
Sherwood, Nancy M. [1 ]
机构
[1] Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada
[2] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA
[3] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QR, England
[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
基金
英国医学研究理事会;
关键词
D O I
10.1210/en.2007-0515
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disruption of the pituitary adenylate cyclase-activating polypeptide (PACAP) gene in mice has demonstrated a role for this highly conserved neuropeptide in the regulation of metabolism and temperature control. Localization of PACAP neurons within hypothalamic nuclei that regulate appetite suggest PACAP may affect feeding and thus energy balance. We used PACAP-null mice to address this question, examining both food intake and energy expenditure. PACAP-null mice were leaner than wild-type littermates due to decreased adiposity and displayed increased insulin sensitivity. The lean phenotype in the PACAP-null mice was completely eliminated if animals were fed a high-fat diet or housed near thermo-neutrality (28 C). Further metabolic analyses of PACAP-null mice housed at 21 C indicated that the reduced body weight could not be explained by decreased food intake, increased metabolic rate, or increased locomotor activity. The thyroid hormone axis of PACAP-null mice was affected, because mRNA levels of hypothalamic TRH and brown adipose tissue type 2 deiodinase were reduced in PACAP-null mice housed at room temperature, and brain deiodinase activity was lower in PACAP-null mice after an acute cold challenge compared with wild-type controls. These results demonstrate that PACAP is not required for the regulation of food intake yet is necessary to maintain normal energy homeostasis, likely playing a role in central cold-sensing mechanisms.
引用
收藏
页码:1571 / 1580
页数:10
相关论文
共 44 条
[11]   The neuropeptide cyclase-activating pituitary adenylate polypeptide and islet function [J].
Filipsson, K ;
Kvist-Reimer, M ;
Ahrén, B .
DIABETES, 2001, 50 (09) :1959-1969
[12]   The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation [J].
Freson, K ;
Hashimoto, H ;
Thys, C ;
Wittevrongel, C ;
Danloy, S ;
Morita, Y ;
Shintani, N ;
Tomiyama, Y ;
Vermylen, J ;
Hoylaerts, MF ;
Baba, A ;
Van Geet, C .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (06) :905-912
[13]   Temperature-sensitive phenotype in mice lacking pituitary adenylate cyclase-activating polypeptide [J].
Gray, SL ;
Yamaguchi, N ;
Vencová, P ;
Sherwood, NM .
ENDOCRINOLOGY, 2002, 143 (10) :3946-3954
[14]   Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism [J].
Gray, SL ;
Cummings, KJ ;
Jirik, FR ;
Sherwood, NM .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (10) :1739-1747
[15]  
Gu Harvest F, 2002, Hum Mutat, V19, P572, DOI 10.1002/humu.9034
[16]   Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis [J].
Hamelink, C ;
Tjurmina, O ;
Damadzic, R ;
Young, WS ;
Weihe, E ;
Lee, HW ;
Eiden, LE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :461-466
[17]  
Harmar AJ, 1998, PHARMACOL REV, V50, P265
[18]   Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) [J].
Hashimoto, H ;
Shintani, N ;
Tanaka, K ;
Mori, W ;
Hirose, M ;
Matsuda, T ;
Sakaue, M ;
Miyazaki, J ;
Niwa, H ;
Tashiro, F ;
Yamamoto, K ;
Koga, K ;
Tomimoto, S ;
Kunugi, A ;
Suetake, S ;
Baba, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (23) :13355-13360
[19]   PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance [J].
Jamen, F ;
Persson, K ;
Bertrand, G ;
Rodriguez-Henche, N ;
Puech, R ;
Bockaert, J ;
Ahrén, B ;
Brabet, P .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1307-1315
[20]  
LABURTHE M, 2003, PITUITARY ADENYLATE, P69